LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Activism » FDA chief counsel soon on GSK payroll

 - UBBFriend: Email this page to someone!    
Author Topic: FDA chief counsel soon on GSK payroll
Neil M Martin
LymeNet Contributor
Member # 2357

Icon 1 posted      Profile for Neil M Martin     Send New Private Message       Edit/Delete Post   Reply With Quote 
July 23, 2008
www.fiercepharma.com

FDA chief counsel soon on GSK payroll
By Christe Bruderlin-Nelson Comment | Forward

In a move that is likely to make industry watchdogs wag their tales, Daniel Troy, formerly chief counsel at FDA from 2001 to 2004, has just signed on to be a senior vice president and general counsel at GlaxoSmithKline.

Famous (and perhaps infamous) for being a good friend to the industry while at the FDA, Troy has been representing pharmaceutical companies and trade associations in their interactions with the agency. For example, the preemption ball began rolling under his tutelage, when FDA began filing amicus briefs in support of pharma companies and medical device makers to protect them from state-based lawsuits, if the products already had met approval and labeling standards. In the fall, the U.S. Supreme Court will determine if it remains possible for patients to sue either once a product receives FDA approval. Troy also is known for telling subordinates to issue fewer warning layers while at FDA.

GSK definitely has a current need for Troy's services, as the U.K. company faces continuing issues regarding its famous antidepressant Paxil and some questionable marketing practices, including federal and congressional investigations.

Between his tenure at FDA and assuming his new role on September 2, Troy's been a partner at the Washington law firm Sidley Austin LLP. In addition, rumor has it that today, Andrew Witty, the new chief executive of GSK, will spill the beans about his strategic review.

--------------------
Neil

Posts: 697 | From Tucson, AZ USA | Registered: Apr 2002  |  IP: Logged | Report this post to a Moderator
luvs2ride
Frequent Contributor (1K+ posts)
Member # 8090

Icon 1 posted      Profile for luvs2ride     Send New Private Message       Edit/Delete Post   Reply With Quote 
Someone said earlier:

"The FDA was put in place to protect big business."

Amen, Brother!

--------------------
When the Power of Love overcomes the Love of Power, there will be Peace.

Posts: 3038 | From america | Registered: Oct 2005  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.